MetabolomicsWorkbenchapplication/xmlhttp://www.metabolomicsworkbench.org/rest/study/study_id/ST001009/mwtabprimary200OKMetabolomicsMass SpectrometryESICachexiaCancerHomo Sapienshttp://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&StudyID=ST001009Grouping:Weight Stable | Gender:MaleGrouping:Control | Gender:MaleGrouping:Weight Losing | Gender:MaleGrouping:Control | Gender:FemaleGrouping:Weight Losing | Gender:FemaleGrouping:Weight Stable | Gender:FemaleMuscleMayo ClinicReversed phase POSITIVE ION MODE.MetabolomicsWorkbenchAcetylcarnitine (C2)Carnitine (C0)Myristoylcarnitine (C14)Oleoylcarnitine (C18:1)Isovalerylcarnitine (C5)Lauroylcarnitine (C12)Palmitoylcarnitine (C16)Butyrylcarnitine (C4)Octanoylcarnitine (C8)Propionylcarnitine (C3)Stearoylcarnitine (C18)muscular tissue, Muscle Tissues, Muscle wasting, primary cancer, Malignant Neoplasm, Neurogenic muscular atrophy, Malignancy, Tissues, Neoplasms, Tissue, Benign Neoplasm, Muscle hypotrophy, Neurogenic muscle atrophy, Benign Neoplasms, Cancers, Tumor, Muscle, Malignant, Amyotrophy involving the extremities, malignant tumor, wasting - muscle, Malignant Neoplasms, Neoplasias, Muscle atrophy, portion of muscle tissue, especially in the lower limbs, Muscle degeneration, Amyotrophy, MT, Benign, malignant neoplasm, neurogenic, amyotrophia, Muscular atrophy, muscle wasting, Neoplasm, Malignancies, textus muscularis, Wasting syndrome., Muscle Tissue, Neoplasia, Cancer, Tumorsbackward, reversed.falseAcyl Carnitines Concentrations in Muscle Tissue of Muscle Wasting in Cancer Cachexia (part-IV)ST0010099606